<div id="readability-page-1">05:23 PM EST, 01/13/2026 (MT Newswires) -- Shattuck Labs ( STTK ) filed a shelf registration statement with US regulators on late Tuesday for the potential sale of up to $200 million in securities, to be offered from time to time.The filing covers common stock, preferred stock, debt securities, warrants and units.The company said the offering proceeds will fund clinical trials, product development, general corporate needs, and potential acquisitions, with unused funds held in safe investments. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

STTK

美国东部时间 2026 年 1 月 13 日下午 5:23（MT Newswires）-- Shattuck Labs（STTK）于周二晚间向美国监管机构提交了一份货架注册声明，计划出售最多 2 亿美元的证券，销售将不定期进行。该文件涵盖普通股、优先股、债务证券、认股权证和单位。公司表示，发行所得将用于临床试验、产品开发、一般企业需求和潜在收购，未使用的资金将用于安全投资。MT Newswires 不提供投资建议。未经授权的复制是严格禁止的

Shattuck Labs 提交了 2 亿美元的混合证券架构申请